Results 121 to 130 of about 17,638 (200)

Lurbinectedin in treating CNS metastases from small cell neuroendocrine prostate cancer-a case report. [PDF]

Front Oncol
Gunuganti A, Barve V, Kelly WJ, Gunuganti V, Brenner A.   +4 more
europepmc   +1 more source

Characterization of Alternaria alternata alternariol monomethyl ether with a potential antiproliferative activity by topoisomerases inhibition; molecular docking and dynamic simulations. [PDF]

Sci Rep
El-Sayed ASA, Aboelez MO, Ezelarab HAA, Ewedah TM, El-Baz AF, Ashraf R, Diab A, Safwat G, Rady AM, El-Mekkawy RM.   +9 more
europepmc   +1 more source

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High-Risk Neuroblastoma: A Multi-Institutional Retrospective Study. [PDF]

Pediatr Blood Cancer
Lerman BJ, King M, Mody R, Onyeama SJ, Marachelian A, Cash T, Federico SM, Granger M, Desai AV, Shusterman S, Foster JH, Sokol E, Greer C, Streby K, Meany HJ, Vo KT, Macy ME, Bagatell R.   +17 more
europepmc   +1 more source

The Influence of TDP1 Inhibitor Usnic Acid Derivative OL9-116 on the Effects of Topotecan in Human Cells. [PDF]

Curr Issues Mol Biol
Kornienko TE, Chepanova AA, Kolobenko MV, Chernyshova IA, Zakharenko AL, Venzel AS, Dyrkheeva NS, Markov AV, Anarbaev RO, Naumenko KN, Luzina OA, Salakhutdinov NF, Ivanisenko VA, Lavrik OI.   +13 more
europepmc   +1 more source

Treatment of leukemic ocular infiltrations with intraarterial chemotherapy in very early mixed relapse of B-cell acute lymphoblastic leukemia. [PDF]

Haematologica
Andrzejewska M, Deręgowski M, Anioł Z, Dezor-Garus J, Stodolska A, Rutkowska S, Przybyłowicz-Chalecka A, Zając-Spychała O, Gotz-Więckowska A, Derwich K.   +9 more
europepmc   +1 more source

Molecular targeted therapy in combination with chemotherapy for the treatment of platinum-resistant/refractory ovarian cancer (PROC): a systematic review and network meta-analysis. [PDF]

Ann Med
Ying T, E S, Ying H.
europepmc   +1 more source

Revisiting Platinum Sensitivity in Relapsed Small-Cell Lung Cancer: Outcomes of Platinum-Containing Doublet Chemotherapy in the 3-6 Month Relapse Window. [PDF]

Curr Oncol
Çil İ, Mıldanoğlu MM, Kutlu Y, Güren AK, Sarı M, Ökten İN, Atalah F, Baydaş T, Kıkılı Cİ, Tural D, Bayramgil A, Balkaya Aykut G, Yumuştutan P, Erçin E, Doğan B, Yılmaz M, Han Ö, Güney B, Olcar S, Odabaş H, Bilici A, Özçelik M.   +21 more
europepmc   +1 more source

Targeting TROP2 and Exploiting AUNIP as a Determinant of ADC Cytotoxicity and Chemosensitivity in HNSCC and ESCA Cancers. [PDF]

Mol Carcinog
Bai J, Ji F, Zhao X, Wang H, Huang X, Wei J, Yang Z, Chen S, Zhang W, Zhang P, He X, Liu L, Xu G.   +12 more
europepmc   +1 more source

TLR4 and RB1 as the Identified Lactate-Related Genes to Predict the Diagnostic Performance, Gene Regulatory Network, and Targeting Drugs in Depression. [PDF]

Hum Mutat
Ding F, Chen J, Wu J, Bian Q.
europepmc   +1 more source

Topoisomerase inhibitors in cervical cancer: mechanistic insights and therapeutic strategies. [PDF]

Mol Med
Reddy Y, Pai P, Das I, Nayak S, D'Souza NV, Shetty MG, Sundara BK.   +6 more
europepmc   +1 more source